Command Palette

Search for a command to run...

Clinical Trials · NCT02889510

Study to Assess the Efficacy of Liraglutide in Patients With Type 2 Diabetes Mellitus

CompletedPhase 3Liraglutide (Approved)
Phase
Phase 3
Recruitment status
Completed
Sponsor
Lecube, Albert, M.D.
Enrollment
76
Start date
Oct 2016
Locations
6 sites, Spain
Primary endpoint
Changes From Baseline on Measurements of Respiratory Function Defined by Forced Expiratory Volume in 1 Second (FEV1)
View Liraglutide compound reference